01/14/2026
Starting hormone therapy earlier — even in perimenopause — can be one of the most powerful ways to protect a woman’s long-term health.
As estrogen begins to decline before menopause, women experience metabolic, cardiovascular, and insulin-resistance changes that increase the risk of type 2 diabetes and heart disease — often years before periods fully stop.
💡 This is why timing matters.
Research shows that initiating HRT during perimenopause or close to the onset of menopause is associated with better outcomes than waiting until symptoms are severe or years have passed. Early support may help:
• Preserve cardiovascular health
• Improve insulin sensitivity and metabolic function
• Protect bone and brain health
• Reduce the long-term effects of estrogen loss
• Improve quality of life — not just manage hot flashes
🩺 Hormone therapy is not about “waiting it out.” It’s about proactive care, individualized dosing, and using hormones as preventive medicine — not a last resort.
Every woman is different, but the data is clear: starting sooner rather than later changes the trajectory of health after 40.
If you’re experiencing perimenopausal symptoms and have been told to “wait until menopause,” it may be time for a more informed conversation.
Treating risk factors that emerge during midlife can reduce a woman’s chances of developing diabetes, heart disease, and other health conditions.
